Free Trial

HUTCHMED (HCM) Competitors

HUTCHMED logo
GBX 230 +5.00 (+2.22%)
As of 04/30/2025 11:50 AM Eastern

HCM vs. SOPH, ITH, GRI, INDV, SLS, ERGO, SLN, BMY, AMYT, and OGN

Should you be buying HUTCHMED stock or one of its competitors? The main competitors of HUTCHMED include Sophos Group plc (SOPH.L) (SOPH), Ithaca Energy (ITH), Grainger (GRI), Indivior (INDV), Standard Life UK Smaller Companies Trust (SLS), Ergomed (ERGO), Silence Therapeutics (SLN), Bloomsbury Publishing (BMY), Amryt Pharma (AMYT), and Origin Enterprises (OGN). These companies are all part of the "pharmaceutical products" industry.

HUTCHMED vs.

Sophos Group plc (SOPH.L) (LON:SOPH) and HUTCHMED (LON:HCM) are both mid-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, dividends, valuation, institutional ownership, earnings, media sentiment, profitability and risk.

In the previous week, HUTCHMED had 2 more articles in the media than Sophos Group plc (SOPH.L). MarketBeat recorded 2 mentions for HUTCHMED and 0 mentions for Sophos Group plc (SOPH.L). Sophos Group plc (SOPH.L)'s average media sentiment score of 0.00 equaled HUTCHMED'saverage media sentiment score.

Company Overall Sentiment
Sophos Group plc (SOPH.L) Neutral
HUTCHMED Neutral

36.5% of HUTCHMED shares are owned by institutional investors. 39.0% of HUTCHMED shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Sophos Group plc (SOPH.L) has higher earnings, but lower revenue than HUTCHMED. HUTCHMED is trading at a lower price-to-earnings ratio than Sophos Group plc (SOPH.L), indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sophos Group plc (SOPH.L)£726.90M0.00N/A£1.70N/A
HUTCHMED£771.01M3.24-£52.98M-£3.92-58.70

Sophos Group plc (SOPH.L) has a net margin of 0.00% compared to HUTCHMED's net margin of -6.87%. Sophos Group plc (SOPH.L)'s return on equity of 0.00% beat HUTCHMED's return on equity.

Company Net Margins Return on Equity Return on Assets
Sophos Group plc (SOPH.L)N/A N/A N/A
HUTCHMED -6.87%-5.71%-5.90%

Sophos Group plc (SOPH.L) received 221 more outperform votes than HUTCHMED when rated by MarketBeat users. Likewise, 80.19% of users gave Sophos Group plc (SOPH.L) an outperform vote while only 78.40% of users gave HUTCHMED an outperform vote.

CompanyUnderperformOutperform
Sophos Group plc (SOPH.L)Outperform Votes
417
80.19%
Underperform Votes
103
19.81%
HUTCHMEDOutperform Votes
196
78.40%
Underperform Votes
54
21.60%

Summary

Sophos Group plc (SOPH.L) beats HUTCHMED on 7 of the 11 factors compared between the two stocks.

Get HUTCHMED News Delivered to You Automatically

Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HCM vs. The Competition

MetricHUTCHMEDDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£2.50B£2.21B£5.57B£2.56B
Dividend Yield4.63%2.92%5.11%4.84%
P/E Ratio-58.703.8722.44132.42
Price / Sales3.24527.72394.66240,284.86
Price / Cash2.4910.2538.1828.16
Price / Book2.636.686.774.55
Net Income-£52.98M£20.70B£3.22B£5.85B
7 Day Performance-0.86%2.16%3.09%2.72%
1 Month Performance-2.95%0.84%-0.14%8.66%
1 Year Performance-22.69%91.87%17.98%110.93%

HUTCHMED Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HCM
HUTCHMED
N/AGBX 230
+2.2%
N/A-22.7%£2.50B£771.01M-58.701,760
SOPH
Sophos Group plc (SOPH.L)
N/AN/AN/AN/A£2.99B£726.90M341.41520
ITH
Ithaca Energy
N/AGBX 136.80
+1.2%
N/A+12.5%£2.85B£3.55B15.62220High Trading Volume
GRI
Grainger
2.8778 of 5 stars
GBX 213.50
+0.7%
GBX 317.50
+48.7%
-16.5%£1.58B£276.05M-1,423.33372Dividend Increase
INDV
Indivior
2.2949 of 5 stars
GBX 667.78
+1.2%
GBX 1,650
+147.1%
-41.0%£1.04B£1.40B-553.691,000Gap Down
SLS
Standard Life UK Smaller Companies Trust
N/AN/AN/AN/A£715.41M£222.48M3.3710
ERGO
Ergomed
N/AN/AN/AN/A£701.00M£152.09M4,641.386
SLN
Silence Therapeutics
N/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading Volume
BMY
Bloomsbury Publishing
2.4943 of 5 stars
GBX 568
+2.0%
GBX 825
+45.2%
+10.9%£458.34M£382.40M12.1534,300
AMYT
Amryt Pharma
N/AN/AN/AN/A£457.11M£210.24M-4.33290Gap Down
OGN
Origin Enterprises
N/AGBX 3
-3.2%
N/A+6.1%£316.76M£183.08B8.6710,000Dividend Increase

Related Companies and Tools


This page (LON:HCM) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners